Skip to main content

Vor Bio to Participate in Upcoming Investor Conferences

CAMBRIDGE, Mass., Nov. 03, 2023 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, today announced that it will participate in the following upcoming investor conferences:

Stifel 2023 Healthcare Conference
Fireside Chat: Tuesday, November 14, 2023 at 3:35 pm ET
Location: Lotte New York Palace Hotel, New York, NY

A live webcast and archived replay of the fireside chat will be available on the investors section of www.vorbio.com.

6th Annual Evercore ISI HealthCONx Conference
Fireside Chat: Wednesday, November 29, 2023 at 3:00 pm ET
Location: Kimpton EPIC Hotel, Miami, FL

Piper Sandler 35th Annual Healthcare Conference
Fireside Chat: Thursday, November 30, 2023 at 2:00 pm ET
Location: Lotte New York Palace Hotel, New York, NY

About Vor Bio
Vor Bio is a clinical-stage cell and genome engineering company that aims to change the standard of care for patients with blood cancers by engineering hematopoietic stem cells to enable targeted therapies post-transplant. For more information, visit: www.vorbio.com.

Contact:

Media & Investors
Sarah Spencer
+1 857-242-6076
sspencer@vorbio.com

 


Primary Logo

Recent Quotes

View More
Symbol Price Change (%)
AMZN  227.54
-1.99 (-0.87%)
AAPL  277.30
-1.48 (-0.53%)
AMD  219.28
+1.31 (0.60%)
BAC  53.85
-0.10 (-0.18%)
GOOG  313.20
-8.89 (-2.76%)
META  669.38
-4.04 (-0.60%)
MSFT  491.86
+8.70 (1.80%)
NVDA  183.16
+0.75 (0.41%)
ORCL  219.77
+2.19 (1.01%)
TSLA  438.36
-16.64 (-3.66%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.